Rayence Co

Rayence Co Market capitalization

The The market capitalization of Rayence Co (228850.KQ) as of Nov 7, 2026 is 97.57 B KRW. In the previous year, The market capitalization was 97.57 B KRW — a change of 0.00% (lower).

Market capitalization

97.57 BKRW

YoY

0.00%

Last updated:

In 2025, Rayence Co's market cap stood at 97.57 B KRW, a 0.00% increase from the 97.57 B KRW market cap in the previous year.

The Rayence Co Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2018
97.57 B KRW
Jan 1, 2019
97.57 B KRW
Jan 1, 2020
97.57 B KRW
Jan 1, 2021
97.57 B KRW
Jan 1, 2022
97.57 B KRW
Jan 1, 2023
97.57 B KRW
Jan 1, 2024
97.57 B KRW
Jan 1, 2025
97.57 B KRW
The Rayence Co Market capitalization history
YEARMarket capitalizationYoY
97.57 BKRW0.00%
97.57 BKRW0.00%
97.57 BKRW0.00%
97.57 BKRW0.00%
97.57 BKRW0.00%
97.57 BKRW0.00%
97.57 BKRW0.00%
97.57 BKRW0.00%
97.57 BKRW0.00%
97.57 BKRW0.00%
97.57 BKRW0.00%
97.57 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rayence Co Stock analysis

What does Rayence Co do? Rayence Co., Ltd. generates revenue through the manufacturing and sale of x-ray detectors, including TFT and CMOS detectors under brand names such as 1012WCA, 17SCC/SGC, 1215CF, 1501CF, and 0712CF. The company also produces intra oral sensors branded as Ez1.0 and Ez1.5, along with mammography machines under the 1724CM and 2434CM series. These products are distributed to both domestic and international markets, serving healthcare providers and medical facilities that require diagnostic imaging equipment. The primary customers for Rayence's detectors and sensors are hospitals, clinics, and medical imaging centers seeking advanced x-ray technology. The firm's product portfolio targets the medical imaging segment, focusing on applications such as dental diagnostics with intra oral sensors and radiological imaging with mammography machines. Revenue streams are derived from direct sales of these branded products to healthcare institutions across multiple regions. Rayence's business model centers on selling specialized medical imaging equipment under its own brand names, with no mention of third-party partnerships or additional services. The company's revenue is directly tied to the purchase of its branded x-ray detectors, intra oral sensors, and mammography machines by healthcare providers who require high-quality diagnostic tools for patient care. Rayence Co is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring Rayence Co's Market Capitalization

Rayence Co's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Rayence Co's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Rayence Co's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Rayence Co’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Rayence Co stock

The market capitalization of Rayence Co is 97.57 B KRW in 2025.

The market capitalization of Rayence Co changed from 97.57 B KRW to 97.57 B KRW, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization Rayence Co since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's KRW, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' KRW varies by industry and company stage. On Eulerpool, you can compare The market capitalization's Rayence Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Rayence Co

All Key Metrics — Rayence Co